The Cardiovascular IP Landscape


The Cardiovascular IP Landscape

January 26, 2021, 12 pm – 1 pm via Zoom

About Our Speakers:

Christy Lea Partner Knobbe Martens

Christy Lea resolves high-stakes patent and trade secret disputes at both the trial and appellate levels. She has represented clients in the medical device and pharmaceutical industries for nearly two decades. Christy is also an accomplished PTAB trial litigator having served as lead counsel in numerous IPRs.

Notably, Christy co-led the firm’s trial team that won a $70 million jury verdict with $21 million in enhanced damages for CardiAQ in a trade secrets misappropriation case against its former vendor, Neovasc Inc. The National Law Journal ranked this verdict as #6 for IP and #21 overall for verdicts that year. The court also granted CardiAQ co-founders Arshad Quadri, M.D. and Brent Ratz co-inventorship of the Neovasc transcatheter mitral valve patent. The decision made Edwards Lifesciences, which acquired CardiAQ for $400 million, co-owner of the Neovasc patent. Christy continues to represent Edwards Lifesciences in district court and before the PTAB. In addition, Christy represented and currently represents Smith & Nephew in numerous litigations and PTAB trials, including in the “negative pressure wound therapy (NPWT) wars” against KCI/Wake Forest, as well as various orthopedics cases.

Sabing Lee Partner Knobbe MartensSabing H. Lee‘s practice includes strategic patent procurement, patent portfolio management, intellectual property due diligence and general counseling on infringement, licensing, international IP protection and post-grant proceedings.  Sabing currently represents clients in a wide range of technologies, with an emphasis on medical devices and procedures and materials science.

In the medical device field, Sabing has worked extensively with cardiovascular, orthopedic, wound care and aesthetic technologies.  He has been involved in the intellectual property strategy and acquisitions of PercuSurge, Inc. (acquired by Medtronic, Inc.), Flex-Foot, Inc. (acquired by Össur hf.), Endius, Inc. (acquired by Zimmer Holdings, Inc.), ev3 Inc. (acquired by Covidien), IDev Technologies, Inc. (acquired by Abbott), and Tornier NV (merged with Wright Medical Group, Inc.), and CardiAQ Valve Technologies, Inc. (acquired by Edwards Lifesciences Corporation).

Sabing currently serves on the Board of Directors for OCTANe, an organization that drives technology industry growth and innovation in Orange County by connecting ideas and people with resources and capital.